This study will compare the results of transarterial chemoembolization (TACE) and microwave ablation (MWA) combination therapy with MWA monotherapy for the treatment of early (stages O and A) hepatocellular carcinoma (HCC). The primary aim is to compare 2-year intrahepatic disease-free survival. Secondary aims are: 1) to determine the clinical feasibility of TACE + MWA in HCC patients with a small burden, and 2) to determine the effect of TACE on radiographic tumor characteristics.
Who may be Eligible
Male or female patients aged 18 to 75 years with a primary diagnosis of hepatocellular carcinoma.